Company Profile

12:31 PM EDT, 04/12/24
Last: $1.44 Change: -0.02 %Change: -1.37% Volume: 200
Detailed Quote
Open: $ 1.44   Volume: 200
High: $ 1.44   Yield(%) n/a
Low: $ 1.44   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): n/a
EPS ($) n/a   Shares Out: n/a
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): n/a
% Price Change (last 13 weeks): n/a
% Price Change (last 26 weeks): n/a
% Price Change (last 52 weeks): n/a
% Price Change (year to date): n/a
Management Effectiveness
Return on Equity (%): n/a
Return on Assets (%): n/a
Return on Invested Capital (%): n/a
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): n/a
Price & Volume
50-day Moving Average: $n/a
200-day Moving Average: $n/a
Avg. Daily Vol. (last 50 days): n/a
Avg. Daily Vol. (last 200 days): n/a
52-wk high: $1.60
52-wk low: $0.76
Bid: $n/a
Ask: $n/a
Company Information
Orexo AB engages in the development of pharmaceuticals based on innovative drug delivery technologies. It operates through the following segments: US Pharma, Digital Therapeutics (DTx), and HQ and Pipelines. The US Pharma segment include sales of own pharmaceuticals in the US. The DTx segment comprises digital therapeutic venture. The HQ and Pipeline segment focuses in the out-licensed pharmaceuticals and costs for research and development, business development, global regulatory, and supply chain. The company was founded by Thomas Lundqvist on November 18, 1994 and is headquartered in Uppsala, Sweden.
Orexo AB
Virdings allé 32 A
Uppsala UP 754 50

Phone: 46.18.780.88.00
Fax: n/a
Per Share Data
Earnings (1year) ($): n/a
Annual Dividend ($): n/a
Current P/E Ratio (ttm): n/a
Book Value ($): n/a
Cash Flow ($): n/a
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): n/a
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): n/a
Current Ratio (x): n/a
LT Debt/Equity (x): n/a
Total Debt/Equity (x): n/a

Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.